GeneDx Holdings Corp. reported a quarterly loss of $0.28 per share, missing the Zacks Consensus Estimate for a $0.06 loss by $0.22 per share. The result also reversed from earnings of $0.28 per share in the year-ago quarter, signaling a sharp deterioration in profitability. The print is likely to weigh on shares, though the article provides no revenue or guidance context.
GeneDx Holdings Corp. reported a quarterly loss of $0.28 per share, missing the Zacks Consensus Estimate for a $0.06 loss by $0.22 per share. The result also reversed from earnings of $0.28 per share in the year-ago quarter, signaling a sharp deterioration in profitability. The print is likely to weigh on shares, though the article provides no revenue or guidance context.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request DemoOverall Sentiment
strongly negative
Sentiment Score
-0.55
Ticker Sentiment
